Perfil de la empresa · Healthcare

Medtronic PLC

MDT · EE. UU.
Bolsa
EE. UU.
País / Región
USA
Fecha de salida a bolsa
13 de enero de 1978
Empleados
95.000
Precio actual
$79.34
En vivo · 18 de junio de 2026
Compra razonable
≤ $65
Entrada con margen de seguridad
Puntuación de crecimiento Baillie
49/100
Floja
Valor intrínseco · Rango en tres niveles Precio actual $79.34 En vivo · Dentro del rango de valor intrínseco razonable

Rango de valoración compuesto · conservador $50–$60 / razonable $60–$80 / optimista $80–$100. A $79.34, Dentro del rango de valor intrínseco razonable.

Al publicar $78 (25 de mayo de 2026)

Aún no hay análisis sobre este valor en tu idioma.

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems and sensors, and InPen, a smart insulin pen. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.

Capitalización100,32 mil MUS$
Ingresos (TTM)36,36 mil MUS$
EBITDA10,08 mil MUS$
Margen neto13,2 %
ROE9,93 %
PER (TTM)20,73
PER previsto13,11
PEG1,54
BPA3,77 US$
Rentabilidad por dividendo3,49 %
Rango de 52 semanas73,31 US$ – 104,70 US$
Precio objetivo de analistas98,00 US$
Recomendación de analistas3.8 / 5

Datos de EODHD, mostrados en la moneda de reporte; solo a título informativo, no constituye asesoramiento de inversión.

Historia

PróximamenteEsta sección se está completando; vuelve pronto.

Posición en el sector

PróximamenteEsta sección se está completando; vuelve pronto.